Harnessing Clinical Success in Complement-Mediated Kidney Diseases to Inform Wider Complement-Mediated Indications
Time: 9:30 am
day: Conference Day One
Details:
- Exploring the role of C3 fragments in the kidney in pathogenesis of C3G and other kidney disease
- Efficacy of C3/C3b inhibition in C3G patients
- Understanding the impact of C3/C3b inhibition on complement deposits in the kidney of C3G patients
